Wake Forest Baptist Medical Center,

Winston-Salem, North Carolina 27517

14 studies enrolling now · 199 studies all time

What they study most

3rd Degree Heart Block, ARDS, ARDS, Human, AV Block, AV Block Complete, Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysms, Abdominal Compartment Syndrome, Acute Coronary Syndrome, Acute Ischemic Stroke, Acute Kidney Injury, Acute Kidney Injury Due to Sepsis

Studies at this site

• A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease — Recruiting now
• Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis — Recruiting now
• Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device — Recruiting now
• A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome — Recruiting now
• REMASTer: REcurrent Brain Metastases After SRS Trial — Recruiting now
• Strategy for Improving Stroke Treatment Response — Recruiting now
• Anticoagulation in ICH Survivors for Stroke Prevention and Recovery — Recruiting now
• A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms — Recruiting now
• Facial Analysis to Classify Difficult Intubation — Recruiting now
• The HIgh-fidelity Hydraulic couPling Upper-arm Cuff Assessment of Limits, Safety, and Effectiveness (HIPULSE) Trial — Recruiting now
• I-DECIDE After Bronchiolitis Hospitalization — Recruiting now
• A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE) — Recruiting now
• StrokeNet Thrombectomy Endovascular Platform — Recruiting now
• CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma — Recruiting now
• Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry — Recruiting now
• Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis — Running, not enrolling
• Brain Energy for Amyloid Transformation in Alzheimer's Disease Study — Completed
• Reliability of Pupil Response to Acute Pain — Stopped early
• A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies — Running, not enrolling
• Dyad Plus Effectiveness/Feasibility — Completed
• Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients — Completed
• SMART TRENDS Study — Completed
• A Study of Subcutaneous Daratumumab Regimens in Combination With Bispecific T Cell Redirection Antibodies for the Treatment of Participants With Multiple Myeloma — Running, not enrolling
• A Study of Talquetamab and Teclistamab Each in Combination With a Programmed Cell Death Receptor-1 (PD-1) Inhibitor for the Treatment of Participants With Relapsed or Refractory Multiple Myeloma — Running, not enrolling
• Embolization of the Splenic Artery After Trauma — Completed
• HPI (Hypotension Prediction Index) Care Trial — Stopped early
• A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment — Running, not enrolling
• Effect of Ketamine and Etomidate During RSI on Long Term Outcomes — Enrolling by invitation
• Effects of Early Weight Bearing on Rehabilitation Outcomes in Patients With Traumatic Ankle and Tibial Plateau Fractures — Completed
• A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05) — Running, not enrolling
• Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS — Running, not enrolling
• A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema — Completed
• Efficacy in iNPH Shunting (PENS) Trial — Running, not enrolling
• Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients — Running, not enrolling
• PRospective Multiple Myeloma Impact Study — Running, not enrolling
• Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML — Completed
• Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for SUI During Minimally Invasive Sacrocolpopexy — Running, not enrolling
• Effects of Muscadine Grape Extract in Men With Prostate Cancer on Androgen Deprivation Therapy — Completed
• Randomized Trial of Sedative Choice for Intubation — Completed
• Assessing Patient Anxiety During Mohs Micrographic Surgery — Completed
• Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam — Completed
• Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial — Running, not enrolling
• A Study of the THERMOCOOL SMARTTOUCH Surround Flow (SF) Catheter With the TRUPULSE Generator for Treatment of Drug Refractory Symptomatic PAF — Completed
• Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria — Completed
• Biodistribution of [11C]PIB in Patients With Risk Factors for Alzheimer's Disease — Enrolling by invitation
• Hidradenitis Suppurativa Mail Survey — Completed
• Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas — Completed
• Efficacy and Safety of Pemigatinib in Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207) — Stopped early
• To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313) — Stopped early
• FlowTriever All-Comer Registry for Patient Safety and Hemodynamics — Completed